ATRC
Atricure Inc
NASDAQ · Health Care
$37.11
+0.91 (+2.51%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 492.57M | 413.02M | 1.17B | 1.22B | 1.20B |
| Net Income | -47,315,656 | -35,706,934 | 86.65M | 93.40M | 92.47M |
| EPS | — | — | — | — | — |
| Profit Margin | -9.6% | -9.1% | 7.4% | 7.7% | 7.7% |
| Rev Growth | +19.3% | +19.3% | -6.7% | +3.2% | +12.0% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 122.14M | 122.14M | 307.18M | 252.39M | 282.45M |
| Total Equity | 800.36M | 800.36M | 682.03M | 771.88M | 789.00M |
| D/E Ratio | 0.15 | 0.15 | 0.45 | 0.33 | 0.36 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | -40,946,910 | -32,617,444 | 118.13M | 127.77M | 131.59M |
| Free Cash Flow | — | — | 83.60M | 108.98M | 92.32M |